ArticleCureus2024
Oncological and Clinical Impacts of Routine Splenic Flexure Mobilization in Anterior Resection.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Splenic flexure mobilization (SFM) is widely regarded as one of the most challenging steps in laparoscopic and robotic colorectal surgery, sparking ongoing debate. Some surgeons routinely advocate for SFM, citing its role in achieving greater left colonic reach, which facilitates a safe, tension-free, and well-vascularized anastomosis while adhering to oncological principles. Conversely, others argue that SFM does not consistently ensure these benefits and may increase the risk of complications, including splenic, bowel, or vascular injuries, as well as unnecessarily prolonging the procedure. While traditional surgical textbooks consider SFM a mandatory step in open colorectal resections, limited evidence supports its necessity in minimally invasive approaches. Aim This study aims to evaluate whether routinely mobilizing the splenic flexure offers advantages from both oncological and clinical perspectives. Materials and methods This retrospective cohort study evaluated the oncological and clinical outcomes of SFM versus splenic flexure preservation (SFP) in anterior resections for malignant pathologies. The study was conducted at New Cross Hospital in Wolverhampton, United Kingdom, over a 24-month period, from March 2022 to March 2024. Anterior resections for benign pathologies were excluded. Data analysis was performed using IBM SPSS Statistics for Windows, Version 24.0 (Released 2016; IBM Corp., Armonk, NY, USA) and Microsoft Excel (Microsoft Corporation, Redmond, WA, USA). Results This study included 94 patients, with 65 undergoing SFM and 29 having it preserved (SFP). No significant differences in baseline demographics (age and gender) were observed between the groups. Oncological outcomes revealed a significantly longer median length of resected specimens in the SFM group, although lymph node counts and high vascular ties were comparable between the groups. There were no differences in R0 resection rates. Clinical outcomes showed similar hospital stays and operation durations in both groups. The SFM group had a slightly higher rate of stoma formation but a lower incidence of anastomotic leaks compared to the SFP group. No significant differences in splenic injuries or other complications were noted. Conclusions Our study suggests that routine SFM offers certain oncological and clinical benefits. The specimens obtained were more complete for pathological staging. The additional length gained from the maneuver not only results in longer specimens but also provides sufficient mobility of the remaining colon, enabling anastomosis with minimal tension, which helps prevent anastomotic leaks. Surgeons may consider adjusting their practices based on the findings of this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.